<SEC-DOCUMENT>0001193125-21-297942.txt : 20211013
<SEC-HEADER>0001193125-21-297942.hdr.sgml : 20211013
<ACCEPTANCE-DATETIME>20211013171606
ACCESSION NUMBER:		0001193125-21-297942
CONFORMED SUBMISSION TYPE:	424B7
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20211013
DATE AS OF CHANGE:		20211013

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
		CENTRAL INDEX KEY:			0001299130
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				161590339
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B7
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-259670
		FILM NUMBER:		211321895

	BUSINESS ADDRESS:	
		STREET 1:		1305 O'BRIEN DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-521-8000

	MAIL ADDRESS:	
		STREET 1:		1305 O'BRIEN DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PACIFIC BIOSCIENCES OF CALIFORNIA INC
		DATE OF NAME CHANGE:	20050829

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NANOFLUIDICS INC
		DATE OF NAME CHANGE:	20040729
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B7
<SEQUENCE>1
<FILENAME>d136370d424b7.htm
<DESCRIPTION>424B7
<TEXT>
<HTML><HEAD>
<TITLE>424B7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(7) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-259670</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT NO. 1 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dated October&nbsp;13,
2021 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(To prospectus dated September&nbsp;20, 2021) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g136370g1013110116949.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Shares of Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pacific Biosciences of California, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement No.&nbsp;1 amends and supplements the prospectus dated September&nbsp;20, 2021 included in a registration statement that we filed
with the SEC using the &#147;shelf&#148; registration process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The &#147;Selling Stockholders&#148; table on page 9 of the prospectus is hereby modified
to reflect the actual number of shares received by the named selling stockholders in the acquisition of Omniome, Inc. by Pacific Biosciences of California, Inc. The information below is based on information provided to us by or on behalf of the
selling stockholders listed below on October&nbsp;12, 2021, and we have not independently verified this information. The percentage of shares beneficially owned below is based on 199,197,784 shares of our Common Stock outstanding on August&nbsp;31,
2021, determined in accordance <FONT STYLE="white-space:nowrap">with&nbsp;Rule&nbsp;13d-3&nbsp;under&nbsp;the&nbsp;Exchange</FONT> Act of 1934, as amended.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement should be read in conjunction with the prospectus, and this prospectus supplement is qualified by reference to the prospectus
except to the extent that the information contained herein supersedes the information contained in the prospectus. Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the prospectus.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SELLING STOCKHOLDERS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Prior to the Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>After the Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name of Selling Stockholder (1)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares of<BR>Common<BR>Stock<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent of<BR>Shares of<BR>Common<BR>Stock<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares of<BR>Common<BR>Stock<BR>Being<BR>Registered<BR>For Resale</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Beneficially<BR>Owned<BR>After the<BR>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent of<BR>Shares of<BR>Common<BR>Stock<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Altitude Ventures Management, LLC (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">368,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.18</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">368,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARCH Venture Fund VIII, L.P. (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,178,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.57</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,178,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Arnold Oliphant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">272,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.13</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">272,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Biomatics Capital Partners, L.P. (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">459,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.22</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">459,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Mullarkey</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">321,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.15</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">321,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Decheng Capital China Life Sciences USD Fund III, L.P. (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,463,872</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,463,872</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Domain Partners VIII, L.P. (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">705,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.34</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">705,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HH <FONT STYLE="white-space:nowrap">SPR-VII</FONT> Holdings Limited (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">911,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.44</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">911,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Madrone Opportunity Fund, L.P. (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,415,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.04</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,165,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.48</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other selling stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,071,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,065,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents less than .01% </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Information concerning the named selling stockholder or future transferees, pledgees, assignees, distributees, donees or successors of or from the selling stockholder or others who later hold the selling stockholder&#146;s interests
will be set forth in supplements to this prospectus, absent circumstances indicating that the change is not material. In addition, post-effective amendments to the registration statement of which this prospectus forms a part will be filed to
disclose any material changes to the plan of distribution from the description in this prospectus.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Altitude Ventures Management, LLC, is the general partner of Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P., and has the power to direct the affairs of Altitude Life Science
Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P., including decisions with respect to voting and sale of shares of common stock.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">ARCH Venture Partners VIII, L.P. (AVP VIII LP) is the sole general partner of ARCH Venture Fund VIII, L.P. (ARCH Venture Fund VIII). ARCH Venture Partners VIII, LLC (AVP VIII LLC) is the sole general partner of AVP VIII LP and has
the power to direct the affairs of ARCH Venture Fund VIII, including decisions with respect to voting and sale of shares of Common Stock. Keith Crandell, Clinton Bybee and Robert Nelsen are the managing directors of AVP VIII LLC and accordingly, may
also be deemed to share the power to direct the disposition and vote of the shares held by ARCH Venture Fund VIII. Each Managing Director disclaims beneficial ownership except to any pecuniary interest therein.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Biomatics Capital Management, LLC is the general partner of Biomatics Capital Partners, L.P., and has the power to direct the affairs of Biomatics Capital Partners, L.P. including decisions with respect to voting and sale of shares
of Common Stock. Boris Nikolic and Julie Sunderland are the managing members of Biomatics Capital Management, LLC and, accordingly, share voting and dispositive power over the shares held by Biomatics Capital Partners, L.P. The managing members
disclaim beneficial ownership except to the extent of their respective pecuniary interests therein.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Decheng Capital Management III (Cayman), LLC is the general partner of Decheng Capital China Life Sciences USD Fund III, L.P., and has the power to direct the affairs of Decheng Capital China Life Sciences USD Fund III, L.P.
including decisions with respect to voting and sale of shares of Common Stock. Xiangmin Cui is the sole manager of Decheng Capital Management III (Cayman), LLC and, accordingly, has voting and dispositive power over the shares held by Decheng
Capital China Life Sciences USD Fund III, L.P. The sole manager disclaims beneficial ownership except to any pecuniary interest therein.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(6)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">One Palmer Square Associates VIII, LLC is the general partner of Domain Partners VIII, L.P., and has the power to direct the affairs of Domain Partners VIII, L.P. including decisions with respect to voting and sale of shares of
Common Stock. James C. Blair, Brian H. Dovey, Brian K. Halak, Jesse I. Treu and Nicole Vitullo are the managing members of One Palmer Square Associates VIII, LLC and, accordingly, share voting and dispositive power over the shares held by Domain
Partners VIII, L.P. Each managing member disclaims beneficial ownership except to the extent of their respective pecuniary interests therein.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(7)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hillhouse Investment Management, Ltd. is deemed to control the voting power of the shares held by HH <FONT STYLE="white-space:nowrap">SPR-VII</FONT> Holdings Limited.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(8)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Madrone Capital Partners, LLC is the general partner of Madrone Opportunity Fund, L.P. and has the power to direct the affairs of Madrone Opportunity Fund, L.P., including decisions with respect to voting and sale of shares of
Common Stock. Greg Penner, Jameson McJunkin, and Thomas Patterson are the managers of Madrone Capital Partners, LLC and, accordingly, share voting and dispositive power over the shares held by Madrone Opportunity Fund, L.P. Each manager disclaims
beneficial ownership except to the extent of their respective pecuniary interests therein.</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g136370g1013110116949.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g136370g1013110116949.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !" 1T# 2(  A$! Q$!_\0
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MX=N%\3ZOJGG1>5>V:VZ)@Y5AW- ',^"O!FF:IX2L+RXEOUEE0EA%=NB_>/0
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MT?VHQ@W%P5&^1R/FR?3/:N2^,7A2W_L!O%>EQ)::UI3K.+B$;6=0>0V.N.M
M'H>M:[IOA[39+_5;N.UM8^KN>I] .Y]JX8?'/P@"KNNII;L<"X:S;8?QKC?B
M)J[ZSI?@'Q1J-I+/H)*S7\2+N4/\N<C\&KTVQ\4>!_$VE"Q@U'2IK65-OV21
MD7 _N[#TH Z33=3L]6T^&^T^YCN;68;DEC;*FN=\3?$KPSX4NDM-0O&DO&Z6
MULGF2#Z@=/QK!TC0YOA1X'\2W(OUN[1#)=V<>TCRLC 7WYVU#\'?"MLGAR/Q
M3J,276LZH[7#7,J[F12> I/3U_&@#7T7XN^%-9U)-.^T7%C=R?<COHO*W'T!
M/&:W?$7B_2/"QL1JLLD?VZ;R8=D9;+<=<=.M9WC[P+8^-M!FM6CABU  &VO"
MGS1,#ZCG';%><_%2SO\ 3M!\ V6IW275[!?+'+.N<2$;>>?;% 'HWBCXE>&O
M!^I1Z?K%S/'<21B51' SC;DCM]*Q?^%[^!.]]=_^ C_X5A^+YK*#]H3P_)J$
MEO':C3VWM<%0G_+3KNXKT'^UO!/_ #_:#_W\AH K3?$?PY!X1A\427$PTN:3
MRDD\EMQ;)'W>O8UT.F:E::OIMOJ-C,LUK<()(Y%Z$5YC\;_L<GPQMS9^2;62
M]A*&$C80<\C'%5/ 5Y<?#WQ@W@?4YG;2[\?:-(N)#QDC)3/^>?K0!Z5JWBO2
MM$UC3-*OI9$N]3<I;*L9(8\=3VZU-KWB/2?#.GM>ZO>QVL(Z%SRY]%'4GZ5Y
MU\3/^2H_#W_K[;_T):HV=E'\1/C5J[:JOVC2?#P$4%J_,;2$XR1WY#'\!0!O
M+\<_"!96D74XK=CA;B2S8(?QKMQKVFOH;ZS#=QSZ>D33&:$[QM R>G\JGN=+
ML+RP:PN;*":T9=I@>,%,?2O-K'P1>^!_"OC.W6_CFT>YMYI;.W&[=!\K9!SQ
MTQT]* +?_"]_ F/^/ZZ_\!'_ ,*NZ1\8?!^N:O:Z787=R]U<OY<2M;,H)^IK
ME_@S?^&K?X<VT>IW6E1W/GRY6Y>,/C=Q][FO2+"^\+W5XD>GW&DRW/5%MWC+
M_ACF@"CXH^(GASPC<1VNI7;M>2?=M;=/,D_$#I^-9^B?%SPIK>J1Z:)[BRNY
M/N)?0F+<?0'IFO/_  ]K.E>%?B]XF;QDGD7MW/FRO+B/*+'DXPQZ#&WGVQ7<
M^,/#_A_XGZ&(=,U/3FU!&62"\A=79,'G[O.* .QU76;71X4DN=Q,C;411DGU
M/L!ZT:7K%KJ]NTMMO^1MKHPY!]>,Y!['I6;J'AV?4-&LK>:Z5[RVB"/(P.R;
MY0&SW&< U:\/:&-%M9%>022R;=Q' 55&%4>P]3R: +NHV%OJ>GSV5W&LEO,A
M1U(Z@UY9X:\*WGA34/%%I.K/;O8EK>;'#K\WZ^M>OU!=6R7=K+;R9V2HR-CK
M@C%)HWI8B4$X=&?(@' I:]&\0_"'5]-D:32&%_:]0K$+*OMCHWX5P=SIM_9.
M4NK&YA8=1)"R_P!*Q:=SZNCB:-2-XLJT5(EO/*VV."5V]%C)-=/HGPZ\2:VR
M,EBUK 3\TMU\F/\ @/4TDFS2I7I05Y,YFVMIKRZCMK:)Y9I&VHB#))KZ,\ >
M#T\*Z*!+M:_N,/<..Q_NCV%'@_P!IOA1/-4&YOV&'N9!R!Z*.PKL*UA'E/G<
M?F'M_<AL+1115GEGB6OZ-IVO_M&6]AJEHEW:MI>XQ2#C(#8KM;KX2^!9[9XS
MX?MH@1_K(V92OOG-5_$WPS.O^+E\1VOB&_TJ]6 0*;4#( SWZ\YJA<_"C5+Z
MW>VN_B#X@FMY!AXRXPP].M ''^&M4OKGX8?$#2I[V:^L]-$D5I<2MN)3#<9_
MX"#^-9OB'2[F?X">#]7MHFD_LN0RR #.%9VY^F0*]CMOA_I&G^!KKPKIWF6U
MM=1,DL_WI&9ARY]36CX=\,VN@^$K7PZ7-W:PQ-$QF4?O%8DD$?C0!8\/ZU:>
M(-!L]4LI5DAN(E?(/W3CE3[@UQWQGUZWTKX>WMDS!KS4L6T$(^\V3R<>P_I5
M)_A%=:5=W$OA'Q9?Z';SOO>U5?,C4^W(_6KNA_"FWM-?CU[Q#J]WK^IQ8\I[
MH82,CH0O/2@"AHVO6_A.+PGX"UK35=+ZP7?/,RF,/SE"I'//'XUN:M\)/!&K
M(X?0X;>1LD26I,1!]<#C]*T_&7@G2O&VF)::DKI)$VZ"YB.)(6]1_A7))\,O
M%JH+5?B3J8L@-NWR?GV^F[=Z4 <AH=OJUS8_$#P"NH3ZG:6-NWV.64[BK _<
MS[^GM7??!C7+;5?AU86L;@7.G@VT\1/S*0>#CW!K=\&^"M*\%::]KIZR223-
MON+F8YDF;U-<YK'PEBDUZ;7/#6M7?A^_GSYWV9<QR$G).,CK^5 '4>-?$\/A
M'PI?:Q(8S)"G[F.0X$DA^ZM>2?$C5;[6_#'P_P!4U*V2VNKJ^$K0QYPH)&WK
MSTQ760?".74-2M;SQ?XGO=?6V;=';2+LBS[C)KHO&7@2U\8_V2)KR2T739_/
M01(#NZ<<]!Q0!PGC/2;#6_V@= L-2M4N;673VWQ/T./,(KN?^%5>!?\ H6;+
M\F_QJGXL^&W_  DOBFV\00:_>Z7>6\'D(ULHR!SDY_X%5/\ X5EKO_12/$/_
M 'T/\: ,WXUV%MIGPNM+&RA6"U@O(4CB7HJ\\5T?COP<OC#PC%';GRM5M$6>
MPG!P4D '&?0X_E3-5^'1UOP5!X<U'7[ZY:*X\\WLJAI'P20#^==O%'Y<*1YS
MM4+GZ4 ?.O\ PF#^*_%OP]^VCR]7L+UK>_B88(<,OS?CC\\UT_@NY3PS\;_%
M6BWS")M59;BU9N!)U; _!C_WS73:C\*=+OOB!;>+HKJ6VN8I4FDAC0%)77^(
M^F:TO&OP^TGQM#"UTTMM?VYS;WL!Q)'SG'N* .L9@H+$X Y)/:O*XO'-WXPT
MWQU!%:P#1].MIHK>Y3.Z5MK?AT';UI9?A;XGOK=K'4?B)J<VGN-KQ+%M9E]"
MVZNQL?!>E:5X.N/#6FH;:UFA>)Y!\SDL,%SZF@#S7X/>!?"^O_#ZWO\ 5-%M
M;JZ:>53*X.2 W'>O2=+\!>%M"U!-0TO1+6VNXP0DL8.1D8/?TKD-,^#U]HUD
MMGIOCS6[2V4EA%#A5!/7C-:^E?#_ %C3M5MKR?QWK=[%"X=K>9ALD']T\]*
M&>'M;T'XGQZC;:KH-M]HTZ<P/;W061@/[P.,@9!KG/'_ ,,/#^A^'KWQ'X?>
M;1-0L$,R/;S,%;'\.">,^U=!XB^%EMJ7B%O$&B:M=Z%JTF?-FMN5D/J5]:SV
M^$NIZRT<?BOQIJ.K64;A_LH3RE?'][DT =9\/=7O->\!Z/J=^<W4T'[QL8W$
M$C=^.,UU%5[2TM["TAM+6)8K>% D<:# 51T%6* "BBB@!#TJ.1%*\J#]1110
M7#<9'&@/"*/PJ<=***"JFXM%%%!D%%%% !1110 4444 %%%% !1110 4444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
